Li, Q., Wang, C., Wang, Y., Sun, L., Liu, Z., Wang, L., . . . Tu, K. (2018). HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. J Exp Clin Cancer Res.
Citação norma ChicagoLi, Qing, et al. "HSCs-derived COMP Drives Hepatocellular Carcinoma Progression By Activating MEK/ERK and PI3K/AKT Signaling Pathways." J Exp Clin Cancer Res 2018.
Citação norma MLALi, Qing, et al. "HSCs-derived COMP Drives Hepatocellular Carcinoma Progression By Activating MEK/ERK and PI3K/AKT Signaling Pathways." J Exp Clin Cancer Res 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.